MucinB5 Gene Polymorphism and Leucocytes Telomere Length... | NCT06498141

Studies
MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases

NCT06498141

Sponsor

Sohag University

Status

Recruiting

Last Update Posted

Jul 12, 2024Actual

Enrollment

100Estimated

Phase

Not provided

Conditions

Mucin B5 rs (35705950) Gene Polymorphism in Interstitial Lung Diseases

Interventions

Not provided

Countries

Egypt

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jul 2024

Overall Recruitment Status or Expanded Access Status

Recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Oct 1, 2023Actual

Primary Completion Date

Oct 1, 2024Estimated

Completion Date

Dec 31, 2024Estimated

First Submitted Date

Jul 6, 2024

First Submission Date that Met QC Criteria

Jul 6, 2024

First Posted Date

Jul 12, 2024Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jul 6, 2024

Last Update Posted Date

Jul 12, 2024Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This is an observertional study aimed at Study the association between Mucin B5 rs (35705950) gene polymorphism and Leucocytes telomere length in relation to interstitial lung diseases.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

6 Months

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

100Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Diseased		patients with interstitial lung diseases fulfilling the inclusion criteria.
Control		Healthy subjects

Interventions

Not provided

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
MucinB5 rs (35705950) gene polymorphism	whether homogenetic or heterogenetic	6 Months
Leucocytes telomere length	Measurement of the relative length of WBCs telomere in patints with interstitial pulmonary fibrosis	6 months

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

This study will include patients with interstitial lung diseases aged above 18 years old.

Exclusion Criteria:

patients with emphysema or obstructive lung diseases.
patients with active cancer
End stage renal failure (GFR < 30 ml/min) or on dialysis
Liver cell failure

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

patients with interstitial lung diseases in our center in sohag university hospital

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Amera Morad Foad, professor	Contact	+201006591449		ameramoradfoad@gmail.com

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Sohag university hosoital	Recruiting	Sohag			Egypt